Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society
October 12, 2024 06:30 ET
|
Benitec Biopharma Inc.
-Subject 1 and Subject 2 experienced durable, clinically meaningful improvements in swallowing at 9-months and 6-months post-BB-301 treatment, respectively, with Subject 2 achieving a Sydney Swallow...
MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN
October 11, 2024 17:15 ET
|
Mangoceuticals, Inc.
DALLAS, TX, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and...
byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination
October 11, 2024 17:15 ET
|
byNordic Acquisition Corp
New York, NY, Oct. 11, 2024 (GLOBE NEWSWIRE) -- byNordic Acquisition Corporation (NASDAQ: BYNO (“BYNO” or the “Company”), a special purpose acquisition company, announced today that the Company has...
Cerence Announces Equity Grant to Employee Under Inducement Plan Pursuant to Nasdaq Listing Rule 5635(c)(4)
October 11, 2024 17:00 ET
|
Cerence Operating Company
BURLINGTON, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (the “Company”), AI for a world in motion, today announced that, in connection with Brian Krzanich’s recent...
FINWARD BANCORP ANNOUNCES THIRD QUARTER DIVIDEND
October 11, 2024 16:40 ET
|
Finward Bancorp
MUNSTER, Ind., Oct. 11, 2024 (GLOBE NEWSWIRE) -- – Finward Bancorp (Nasdaq: FNWD) (the “Bancorp” or “Finward”), the holding company for Peoples Bank (the “Bank”), today announced that on September...
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 11, 2024 16:30 ET
|
Fulcrum Therapeutics, Inc.
CAMBRIDGE, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives...
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
October 11, 2024 16:30 ET
|
Denali Capital Acquisition Corp.
NEW YORK, NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...
MidWestOne Financial Group, Inc. Announces Third Quarter 2024 Earnings Conference Call
October 11, 2024 16:15 ET
|
MidWestOne Bank
IOWA CITY, Iowa, Oct. 11, 2024 (GLOBE NEWSWIRE) -- MidWestOne Financial Group, Inc. (Nasdaq: MOFG) (“MidWestOne” or the “Company”), parent company of MidWestOne Bank, today announced that its third...
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
October 11, 2024 16:15 ET
|
Nanobiotix S.A.
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 11 oct. 2024 (GLOBE NEWSWIRE) -- Paris, France, le 11...
Voting Rights and Shares Capital of the Company
October 11, 2024 16:15 ET
|
Nanobiotix S.A.
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Oct. 11,...